Lower osteopontin plasma levels are associated with superior outcomes in advanced non-small-cell lung cancer patients receiving platinum-based chemotherapy: SWOG Study S0003 (Q37121729)
Jump to navigation
Jump to search
scientific article published on 08 September 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Lower osteopontin plasma levels are associated with superior outcomes in advanced non-small-cell lung cancer patients receiving platinum-based chemotherapy: SWOG Study S0003 |
scientific article published on 08 September 2008 |
Statements
1 reference
Lower osteopontin plasma levels are associated with superior outcomes in advanced non-small-cell lung cancer patients receiving platinum-based chemotherapy: SWOG Study S0003 (English)
1 reference
David R Gandara
1 reference
Philip C Mack
1 reference
Mary W Redman
1 reference
Kari Chansky
1 reference
Stephen K Williamson
1 reference
Nichole C Farneth
1 reference
Primo N Lara
1 reference
Wilbur A Franklin
1 reference
Quynh-Thu Le
1 reference
John J Crowley
1 reference
SWOG
1 reference
8 September 2008
1 reference
1 reference
4771-4776
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference